Global AI in Clinical Trials Market to Show Tremendous Growth at a CAGR of ~12% by 2032
By GlobeNewswire Published on May 7, 2025, 22:00 IST
New York, USA, May 07, 2025 (GLOBE NEWSWIRE) — Global AI in Clinical Trials Market to Show Tremendous Growth at a CAGR of ~12% by 2032 | DelveInsight
The demand for AI in clinical trials is experiencing strong growth, primarily fueled by the rising global prevalence of chronic illnesses like diabetes, cardiovascular diseases, respiratory conditions, and cancer. This growth is further bolstered by increasing investments and funding dedicated to enhancing drug discovery and development. Additionally, the expanding trend of strategic alliances and partnerships among pharmaceutical, biotechnology, and medical device firms is significantly contributing to the accelerated adoption of AI-driven clinical trial technologies.
DelveInsight's AI in Clinical Trials Market Insights report provides the current and forecast market analysis, individual leading AI in clinical trials companies' market shares, challenges, AI in clinical trials market drivers, barriers, trends, and key market AI in clinical trials companies in the market.
Key Takeaways from the AI in Clinical Trials Market Report As per DelveInsight estimates, North America is anticipated to dominate the global AI in clinical trials market during the forecast period.
In the product segment of the AI in clinical trials market, the software category had a significant revenue share in 2024.
Notable AI in clinical trials companies such as TEMPUS, NetraMark, ConcertAI, AiCure, Medpace, Inc., ICON plc, Charles River Laboratories, Dassault Systèmes, Oracle, Certara, Cytel Inc., Phesi, DeepHealth, Unlearn.ai, Inc., H1, TrialX, Suvoda LLC, Risklick, Lokavant, Research Solutions, and several others are currently operating in the AI in clinical trials market.
and several others are currently operating in the AI in clinical trials market. In March 2025, Suvoda launched Sofia, an AI-powered assistant designed to streamline clinical trial management. Built to support study teams, Sofia simplifies access to and review of critical trial information by delivering intelligent, real-time insights. This innovation enhances operational efficiency, reduces manual workload, and empowers teams to make faster, data-driven decisions throughout the trial lifecycle.
launched Sofia, an AI-powered assistant designed to streamline clinical trial management. Built to support study teams, Sofia simplifies access to and review of critical trial information by delivering intelligent, real-time insights. This innovation enhances operational efficiency, reduces manual workload, and empowers teams to make faster, data-driven decisions throughout the trial lifecycle. In December 2024, ConcertAI and NeoGenomics announced the launch of CTO-H, a next-generation AI software solution for research analytics, clinical trial design, and operational optimization. CTO-H delivers an unparalleled research data platform, offering unmatched scale, longitudinal patient insights, and deep biomarker data, enabling more precise, efficient, and data-driven clinical development strategies.
announced the launch of CTO-H, a next-generation AI software solution for research analytics, clinical trial design, and operational optimization. CTO-H delivers an unparalleled research data platform, offering unmatched scale, longitudinal patient insights, and deep biomarker data, enabling more precise, efficient, and data-driven clinical development strategies. In June 2024, Lokavant launched Spectrum™, the first AI-driven clinical trial feasibility solution designed to optimize trial performance across the entire clinical development value chain. Spectrum empowers study teams to predict, manage, and optimize trial timelines and costs in real-time.
To read more about the latest highlights related to the AI in clinical trials market, get a snapshot of the key highlights entailed in the Global AI in Clinical Trials Market Report
AI in Clinical Trials Overview
Artificial intelligence (AI) is revolutionizing clinical trials by enhancing efficiency, accuracy, and patient outcomes across the entire trial lifecycle. AI-powered tools enable faster patient recruitment by analyzing electronic health records and identifying eligible candidates based on complex inclusion and exclusion criteria. This targeted approach reduces trial enrollment time and improves diversity among participants. Additionally, AI can optimize trial design by simulating outcomes using real-world data, allowing researchers to refine protocols and predict potential risks, ultimately leading to more robust and reliable results.
Moreover, AI facilitates real-time monitoring and data analysis during trials, enabling early detection of adverse events and anomalies. Machine learning algorithms can process vast amounts of data from wearable devices, lab results, and patient-reported outcomes to identify patterns that might be overlooked by traditional methods. This enhances decision-making and allows for adaptive trial designs, where protocols can be modified in response to interim findings. As regulatory bodies grow more comfortable with AI-driven methodologies, the integration of AI in clinical trials holds the promise of accelerating drug development while ensuring safety and efficacy.
AI in Clinical Trials Market Insights
North America held the largest share of the AI in clinical trials market in 2024. This leading position is driven by several key factors, including the increasing burden of chronic diseases, substantial R&D investments, and a growing volume of clinical trials in the region. The market is also benefiting from the rise in research collaborations and strategic partnerships among pharmaceutical and medical device companies, alongside the continuous development of sophisticated AI technologies.
Major players in the North American market are making significant R&D investments to develop cutting-edge AI tools aimed at streamlining clinical trials. For instance, in October 2022, Phesi introduced its AI-driven Trial Accelerator platform, which enhances clinical trial planning through real-time scenario analysis. Utilizing the world's most comprehensive clinical trial database, this SaaS platform helps optimize patient recruitment, endpoint determination, country selection, and site allocation—boosting trial efficiency and outcomes.
Likewise, in October 2023, H1 launched GenosAI, a generative AI feature integrated into its Trial Landscape platform. GenosAI is designed to improve clinical trial decision-making by enabling pharmaceutical companies to analyze complex data, simplify trial-related queries, and expedite the selection of sites and principal investigators, thereby facilitating quicker and more strategic trial initiations.
As a result, these factors are expected to drive substantial growth in the North American AI in clinical trials market throughout the 2025–2032 forecast period.
To know more about why North America is leading the market growth in the AI in clinical trials market, get a snapshot of the AI in Clinical Trials Market Outlook
AI in Clinical Trials Market Dynamics
The AI in clinical trials market is experiencing significant growth, driven by advancements in artificial intelligence, machine learning, and data analytics. AI technologies are being increasingly adopted to streamline clinical trial processes, such as patient recruitment, data collection, and monitoring. AI-powered tools help researchers identify suitable candidates faster, reducing the time and costs associated with recruitment. Additionally, AI aids in personalized treatment regimens by analyzing large datasets to identify optimal patient profiles and predict outcomes more accurately.
One of the major factors fueling the market's growth is the need for improving efficiency in clinical trials. AI facilitates real-time monitoring of patient health, enabling researchers to detect potential issues early and make data-driven decisions. By automating time-consuming tasks, AI reduces human error, improves trial design, and accelerates the pace of development for new therapies. This increased efficiency is especially critical as the pharmaceutical industry faces growing pressure to bring drugs to market quickly due to competitive pressures and a rising demand for novel treatments.
Another key driver in the AI in clinical trials market is the increasing complexity of modern drug development. With more targeted therapies, such as immunotherapies and gene therapies, clinical trials require sophisticated designs to accommodate diverse patient populations and intricate treatment regimens. AI technologies, including predictive analytics and natural language processing, help streamline this complexity by analyzing vast datasets to uncover meaningful insights. This supports the creation of more robust trial designs and accelerates decision-making processes, ultimately reducing costs.
Despite its advantages, the adoption of AI in clinical trials faces challenges, such as concerns around data privacy, regulatory compliance, and the need for skilled personnel. Healthcare data is highly sensitive, and regulatory bodies are still adapting to ensure AI tools meet the necessary standards for clinical use. Furthermore, while AI can greatly assist in data analysis, the technology still requires human oversight to interpret results and ensure that ethical guidelines are followed. Addressing these challenges will be crucial for widespread AI adoption and for realizing its full potential in clinical trials.
Looking ahead, the AI in clinical trials market is expected to expand further with the integration of more advanced AI capabilities, including deep learning and real-time data integration from wearables and remote monitoring devices. As healthcare systems continue to digitize and AI technologies evolve, their use in clinical trials will likely become more ubiquitous, making trials faster, cheaper, and more effective. The market is poised for continued growth, with AI playing a pivotal role in shaping the future of clinical research.
Get a sneak peek at the AI in clinical trials market dynamics @ AI in Clinical Trials Market Dynamics Analysis Report Metrics Details Coverage Global Study Period 2022–2032 AI in Clinical Trials Market CAGR ~12% AI in Clinical Trials Market Size by 2032 USD 3.3 Billion Key AI in Clinical Trials Companies TEMPUS, NetraMark, ConcertAI, AiCure, Medpace, Inc., ICON plc, Charles River Laboratories, Dassault Systèmes, Oracle, Certara, Cytel Inc., Phesi, DeepHealth, Unlearn.ai, Inc., H1, TrialX, Suvoda LLC, Risklick, Lokavant, Research Solutions, among others
AI in Clinical Trials Market Assessment AI in Clinical Trials Market Segmentation AI in Clinical Trials Market Segmentation By Product: Software and Services AI in Clinical Trials Market Segmentation By Technology: Machine Learning (ML), Natural Language Processing (NLP), and Others AI in Clinical Trials Market Segmentation By Application: Clinical Trial Design & Optimization, Patient Identification & Recruitment, Site Identification & Trial Monitoring, and Others AI in Clinical Trials Market Segmentation By Therapeutic Area: Oncology, Cardiology, Neurology, Infectious Disease, Immunology, and Others AI in Clinical Trials Market Segmentation By End-User: Pharmaceutical & Biotechnology Companies and Medical Device Companies AI in Clinical Trials Market Segmentation By Geography : North America, Europe, Asia-Pacific, and Rest of World
Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Which MedTech key players in the AI in clinical trials market are set to emerge as the trendsetter explore @ AI in Clinical Trials Companies
Table of Contents 1 AI in Clinical Trials Market Report Introduction 2 AI in Clinical Trials Market Executive Summary 3 Competitive Landscape 4 Regulatory Analysis 5 AI in Clinical Trials Market Key Factors Analysis 6 AI in Clinical Trials Market Porter's Five Forces Analysis 7 AI in Clinical Trials Market Layout 8 AI in Clinical Trials Market Company and Product Profiles 9 KOL Views 10 Project Approach 11 About DelveInsight 12 Disclaimer & Contact Us
Interested in knowing the AI in clinical trials market by 2032? Click to get a snapshot of the AI in Clinical Trials Market Trends
Related Reports
Artificial Intelligence in Drug Commercialization Market
Artificial Intelligence in Drug Commercialization Market Insight, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key AI in drug commercialization companies, including EVERSANA, Lyfegen, Syneos Health, McKinsey & Company, ICON plc., Clarivate., Thermo Fisher Scientific Inc., Viseven, ZS Associates, Cloud Pharmaceuticals Inc., among others.
Artificial Intelligence in Precision Medicine Market
Artificial Intelligence in Precision Medicine Market Insight, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key AI in precision medicine companies, including TEMPUS, GE HealthCare, Qure.ai, Envisionit Deep AI (Pty) Ltd., Avicenna.AI, Aignostics, Inc., Proscia Inc., Ultivue, Inc., Prenosis, Inc., IBEX, Cleerly, Inc., Paige AI, Inc., Densitas® Inc., Photocure ASA, iCAD, Inc., Eko Health, Inc., Owkin, Inc, Massive Bio, Deep Bio Inc., Atomwise Inc., among others.
Artificial Intelligence In Drug Discovery Market
Artificial Intelligence In Drug Discovery Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key AI in drug discovery companies, including IBM Corporation, Numedii Inc, Deep Genomics, NVIDIA Corporation, Atomwise Inc, Cloud Pharmaceuticals Inc, Alphabet Inc (DeepMind), Insilico Medicine, BenevolentAI, Exscientia, Cyclia, Valo Health, Owkin Inc, Verge Genomics, BioSymetrics, among others.
Artificial Intelligence in Medical Imaging Market
Artificial Intelligence in Medical Imaging Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key AI in medical imaging companies, including Microsoft, Siemens Healthineers, GE Healthcare, NVIDIA Corporation, Philips Healthcare, Arterys, Butterfly Network, Enlitic, HeartFlow, Digital Diagnostics, among others.
Artificial Intelligence in Life Sciences Market
Artificial Intelligence in Life Sciences Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key AI in life sciences companies, including IBM Corporation, Atomwise, Inc., Nuance Communications, Inc., NuMedii, Inc., AiCure LLC, APIXIO, Inc., Insilico Medicine, Inc., Enlitic, Inc., Sensely, Inc., Zebra Medical Vision, among others.
DelveInsight's Pharma Competitive Intelligence Service: Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion.
Other Business Pharmaceutical Consulting Services
Healthcare Conference Coverage
Pipeline Assessment
Healthcare Licensing Services
Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our Due Diligence Case Study
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
6 hours ago
- Business Upturn
PFMCrypto Announces Free and Sustainable Cloud Mining Technology for Bitcoin Users
Los Angeles, California, June 08, 2025 (GLOBE NEWSWIRE) — PFMCrypto, the cloud mining service operated by UK-registered and FCA-regulated Precision Financial Management Ltd (Company No. 11719896), has officially launched a sustainable mining platform that combines user-friendly cloud contracts with renewable energy. The company's service allows users to participate in Bitcoin mining without owning hardware, while its operations are powered by solar and wind energy—minimizing environmental impact and reducing operational costs. As technology continues to evolve, the global shift toward renewable energy is accelerating. PFMCrypto powers its cloud mining operations using renewable energy sources such as solar and wind power. This significantly reduces mining costs while returning excess electricity to the grid. This approach not only conserves energy but also delivers sustainable returns to investors—highlighting the enormous potential of green-powered mining. In the fast-paced world of cryptocurrencies, simplicity and profitability are key. For beginners seeking a reliable source of income, PFMCrypto's cloud mining service is an especially appealing option. What Is PFMCrypto Cloud Mining? PFMCrypto cloud mining is a remote cryptocurrency mining solution that supports a range of digital assets, including Bitcoin. Users leverage the mining company's computational power to earn profits without investing in hardware or handling technical maintenance. Through access to high-powered mining farms, PFMCrypto enables users to benefit from ongoing crypto mining rewards as complex blockchain problems are solved in real time. Key Benefits of PFMCrypto Cloud Mining Easy Investment: Users can invest effortlessly without complicated procedures. No Hardware Required: There's no need to buy expensive mining equipment, lowering the barrier to entry. No Technical Expertise Needed: Ideal for beginners, with minimal technical requirements. Zero Operational Costs: No electricity, maintenance, or other overhead expenses for the user. Flexible and Reliable: Users can adjust their investment strategy according to their individual goals. Instant Start: interested users can quickly start mining without cumbersome preparations. Why Choose PFMCrypto? PFMCrypto is committed to clean and efficient energy solutions. Founded in 2018 in the UK, the platform has grown to serve more than 9.2 million users globally. Since its inception, the company has focused exclusively on Bitcoin mining. Today, PFMCrypto operates more than 20 large-scale mining farms and reportedly accounts for approximately 6.2% of the global mining hash rate. Platform Advantages Cutting-Edge Equipment: PFMCrypto uses top-tier mining hardware from manufacturers like Bitmain, Antminer, and other energy-efficient rigs to ensure stable and high-yield mining performance. Legal and Globally Trusted: Operated by FCA-regulated Precision Financial Management (PFM) Ltd , PFMCrypto complies with all UK financial regulations and serves a global user base of over 9.2 million real users. User-Friendly Interface: Designed with intuitive navigation so even beginners can easily manage their accounts. Multi-Crypto Support: Supports settlement in various popular cryptocurrencies including USDT-TRC20, BTC, ETH, LTC, USDC, BNB, USDT-ERC20, BCH, DOGE, SOL (Solana), XRP, and more. Stable Daily Returns: Mining contracts yield daily returns, with principal automatically refunded upon contract expiration to protect investment security. Expert Team: PFMCrypto boasts a professional IT team and 24/7 live customer support to assist users at all times. Affiliate Program: Invite friends and earn referral bonuses of up to $18,999. How to Join PFMCrypto Sign up today and receive a $10 welcome bonus (plus $0.60 daily check-in rewards). a Contract: After registering, select a mining contract that suits your goals and budget. PFMCrypto offers a range of plans to fit both new and seasoned miners. Earning: Once your mining contract is activated, the platform's advanced technology handles the rest—ensuring your operation runs efficiently and maximizes your potential profits. Sample Investment Plans Trial Contract: Investment: $100 | Net Profit: $106.6 Classic Contract: Investment: $500 | Net Profit: $530.75 Classic Contract: Investment: $3,000 | Net Profit: $3,888 Prepaid Contract: Investment: $5,000 | Net Profit: $7,370 Advanced Contract: Investment: $10,000 | Net Profit: $17,240 As your mining activity progresses, your account will begin to accumulate earnings. You can track performance through your dashboard and withdraw profits whenever you're ready. In Summary PFMCrypto is a legally registered UK company authorized and regulated by the UK Financial Conduct Authority (FCA), adhering strictly to local regulations. The platform offers a seamless, low-barrier entry into crypto mining for both beginners and experienced investors, aiming to help users maximize their earnings with minimal effort. Start your hassle-free cloud mining journey with PFMCrypto and boost your income today! New users can get a $10 bonus. For more information, visit the official PFMCrypto website: Or download the mobile app from Google Play and the Apple App Store . Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Business Upturn
11 hours ago
- Business Upturn
ASUS Republic of Gamers Announces the ROG Xbox Ally and ROG Xbox Ally X, Raising the Standard for Gaming Handhelds
KEY POINTS All-day comfort : Redesigned chassis is purpose-built to fit the hands like a real gamepad : Redesigned chassis is purpose-built to fit the hands like a real gamepad Seamless software experience : New Xbox ® software offers the best of Xbox and Windows PC gaming in one handheld : New Xbox software offers the best of Xbox and Windows PC gaming in one handheld Efficiency and performance: Two new processors offer incredible AAA and indie gaming experiences LOS ANGELES, June 08, 2025 (GLOBE NEWSWIRE) — ASUS Republic of Gamers (ROG) is proud to announce an all-new series of Ally handhelds built from the ground up with improved ergonomics and a seamless player-first user experience. Developed in partnership with the incredible team at Xbox, the new ROG Xbox Ally and ROG Xbox Ally X offer best-in-class ergonomics and a full-screen Xbox experience that marries the best of Xbox and PC gaming in one cohesive package. 'We wanted to take our handheld to the next level, but we could not do it alone.' said Shawn Yen, Head of the Consumer product team at ASUS. 'This revolutionary partnership with Microsoft allowed us to forge a brand new device with ROG muscle and the soul of Xbox.' The ROG Xbox Ally sports an AMD Ryzen™ Z2 A Processor with incredible power efficiency, while the ROG Xbox Ally X offers the new AMD Ryzen™ AI Z2 Extreme Processor for next-level gaming performance. Both launch holiday 2025 in select markets, with additional markets to follow. All-day comfort The ROG Xbox Ally and the ROG Xbox Ally X feature a completely redesigned chassis. Gaming on handheld is a very personal experience, and comfort in the hand is a key pillar of a well-designed device. With years of feedback on the original Ally and Ally X, the ROG Xbox Ally series offers a more comfortable grip than ever, inspired by Xbox. With a redesigned palm rest and texturing patterns to keep gamers locked on target, the ROG Xbox Ally series truly raises the bar for comfort with a handheld gaming device. The ROG Xbox Ally X also features impulse triggers, improving the haptics in supported games. These triggers allow for more nuance and immersion and are a feature that Xbox gamers have come to expect with their controllers. These devices are the most comfortable and immersive handhelds ever built by ROG. Seamless software experience While the ROG Armoury Crate Special Edition software made the original Ally easy to use, ROG and Xbox aimed to make handheld gaming even more seamless on Windows 11. 'We wanted to create an authentic Xbox experience in a handheld form factor,' explained Roanne Sones, CVP at Xbox. 'With ROG, we made it happen on the Xbox Ally and Xbox Ally X.' As soon as players power on the device, they enter the full screen Xbox experience. Powered by Windows 11 underneath, this software has been optimized for the ROG Xbox Ally, reducing system overhead and offering easy joystick and button navigation. Quick access to settings and customizable widgets are available via Game Bar with a single press of the Xbox button. But with the full freedom of Windows 11 running under the hood, games and mods from other sources are still easily accessible. The ROG Xbox Ally series offers the power of Xbox, the craftsmanship of ROG, and the versatility of Windows, all in one cohesive device. Efficiency and performance The ROG Xbox Ally X features the new top-of-stack AMD Ryzen AI Z2 Extreme Processor, giving it plenty of horsepower even in AAA games. Combined with software optimizations from the new Xbox experience, the ROG Xbox Ally X stands ready to provide gamers with next-gen handheld performance. 'Battery life is paramount on handhelds like the ROG Xbox Ally and Ally X,' said Jack Huynh, Senior Vice President and General Manager of AMD. 'The Ryzen Z2 series improves efficiency over the previous generation while still offering excellent performance in modern games.' The ROG Xbox Ally offers console-caliber performance with its AMD Ryzen Z2 A Processor. At the same time, its ultra-efficient design at low wattages and its 60Wh battery produce improved battery life. Meanwhile, the ROG Xbox Ally X takes performance to greater heights, offering more room for graphical fidelity at higher framerates with the AMD Ryzen AI Z2 Extreme Processor. Both chips are primed to take full advantage of AMD's latest software suite for graphics and performance improvements, including AMD FidelityFX™ Super Resolution (FSR), Radeon Super Resolution (RSR), and AMD Fluid Motion Frames (AFMF) frame generation, the latter of which can offer better framerates for improved smoothness. In a nod to the future, the AMD Ryzen AI Z2 Extreme-equipped ROG Xbox Ally X features an NPU. With these next-generation chips, the ROG Xbox Ally X will be ready to power the latest AI features as they are introduced. At launch this holiday, the ROG Xbox Ally and ROG Xbox Ally X will be available in Australia, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Italy, Japan, Korea, Mexico, the Netherlands, New Zealand, Norway, Poland, Portugal, Saudi Arabia, Singapore, Spain, Sweden, Switzerland, Thailand, Turkey, the United Arab Emirates, the United Kingdom, and the United States, with availability to follow for other markets where ROG Ally series products are sold today. For more information, please visit Users can also sign up on the page to get notified when pre-orders go live. SPECIFICATIONS ROG Xbox Ally X (2025) Operating System Windows 11 Home Comfort & input Contoured grips inspired by Xbox Wireless Controllers deliver all-day comfort, complete with impulse triggers for enhanced control ABXY buttons / D-pad / L & R impulse triggers / L & R bumpers / Xbox button / View button / Menu button / Command Center button / Library button / 2x assignable back buttons / 2x full-size analog sticks / HD haptics / 6-Axis IMU Processor AMD Ryzen™ AI Z2 Extreme Processor Display 7' FHD (1080p) IPS, 500 nits, 16:9120Hz refresh rateFreeSync Premium Corning® Gorilla® Glass Victus® + Corning DXC Anti-Reflection Memory 24GB LPDDR5X-8000 Storage 1TB M.2 2280 SSD for easier upgrade Network and Communication Wi-Fi 6E (2 x 2) + Bluetooth® 5.4 I/O Ports 1x USB4® with DisplayPort™ 2.1 / Power Delivery 3.0, Thunderbolt™ 4 compatible 1x USB 3.2 Gen 2 Type-C® with DisplayPort™ 2.1 / Power Delivery 3.0 1x UHS-II microSD card reader (supports SD, SDXC and SDHC; UHS-I with DDR200 mode) 1x 3.5mm Combo Audio Jack Battery 80Wh Dimensions 290.8 (W) x 121.5 (D) x 50.7 (H) mm Weight 715 grams Included ROG Xbox Ally X 65W charger Stand ROG Xbox Ally (2025) Operating System Windows 11 Home Comfort & input Contoured grips inspired by Xbox Wireless Controllers deliver all-day comfort ABXY buttons / D-pad / L & R Hall Effect analog triggers / L & R bumpers / Xbox button / View button / Menu button / Command Center button / Library button / 2x assignable back buttons / 2x full-size analog sticks / HD haptics / 6-Axis IMU Processor AMD Ryzen™ Z2 A Processor Display 7' FHD (1080p) IPS, 500 nits, 16:9 120Hz refresh rate FreeSync Premium Corning® Gorilla® Glass Vitus® + Corning DXC Anti-Reflection Memory 16GB LPDDR5X-6400 Storage 512GB M.2 2280 SSD for easier upgrade Network and Communication WiFi 6E (2 x 2) + Bluetooth® 5.4 I/O Ports 2x USB 3.2 Gen 2 Type-C® with DisplayPort™ 2.1 / Power Delivery 3.0 1x UHS-II microSD card reader (supports SD, SDXC and SDHC) 1x 3.5mm Combo Audio Jack Battery 60Wh Dimensions 290.8 (W) x 121.5 (D) x 50.7 (H) mm Weight 670 grams Included ROG Xbox Ally 65W charger Stand NOTES TO EDITORS ROG Facebook: ROG X (Twitter): ASUS Pressroom: ASUS Canada Facebook: ASUS Canada Instagram: ASUS Canada YouTube: ASUS Global Twitter: About ROG Republic of Gamers (ROG) is an ASUS sub-brand dedicated to creating the world's best gaming hardware and software. Formed in 2006, ROG offers a complete line of innovative products known for performance and quality, including motherboards, graphics cards, system components, laptops, desktops, monitors, smartphones, audio equipment, routers, peripherals and accessories. ROG participates in and sponsors major international gaming events. ROG gear has been used to set hundreds of overclocking records and it continues to be the preferred choice of gamers and enthusiasts around the world. To become one of those who dare, learn more about ROG at A photo accompanying this announcement is available at Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Business Upturn
11 hours ago
- Business Upturn
Miningcoop announced that it will comprehensively increase the interest rate of cloud mining contracts, and the daily return on investment for mining Bitcoin & Dogecoin can reach 6.8%.
By GlobeNewswire Published on June 8, 2025, 19:00 IST London, United Kingdom , June 08, 2025 (GLOBE NEWSWIRE) — As global demand for passive cryptocurrency income continues to surge in 2025, cloud mining has quickly become the preferred strategy for a growing number of investors. Amid rising financial uncertainty worldwide, investor interest in decentralized assets like Bitcoin (BTC) has soared, driving unprecedented demand for legal, secure, convenient, and high-return crypto investment platforms. Leading this transformation is Miningcoop—widely recognized as the most profitable and trusted Bitcoin and Dogecoin cloud mining platform of 2025. Unlike traditional mining setups, Miningcoop requires no expensive hardware or complex installations. With just a few clicks, users can begin earning stable daily returns through cloud-based crypto mining. Miningcoop: Delivering the Most Trusted Daily Crypto ROI Solutions in 2025 (Awarded Best Cloud Mining Platform) A key advantage of Miningcoop lies in its AI-powered, transparent, and quantifiable income model. Users can flexibly select from a variety of short- and medium-term mining contracts based on their budgets and profit goals. Contracts pay daily and automatically return the principal upon maturity—with no hidden fees or costs. Miningcoop's most popular mining contracts feature: · Contract durations starting from just 1 day · Daily earnings of up to $4,400, based on real mining pool output · Multi-currency support for deposits and withdrawals (BTC, ETH, DOGE, USDT) · Zero hardware costs, no maintenance required � Visit now to claim your free $100 bonus Example Earnings Table: The following chart illustrates the potential profit you can achieve. Mining Model Contract Price ($) Daily Rate (%) Daily Earnings ($) Duration (Days) Total Earnings ($) iPollo V1 Ultra 200 4.00% 8.00 1 8.00 Goldshell Mini-DOGE III 500 3.20% 16.00 2 32.00 Antminer L7 3,800 4.15% 157.70 5 788.50 Antminer S21 XP+ Hyd 30,000 6.80% 2,040.00 3 6,120.00 Withdrawals are supported in BTC, ETH, DOGE, or USDT. The minimum withdrawal amount is $200. Earnings are calculated and distributed automatically each day. Beginners Welcome: Start Your Crypto Passive Income with Zero Experience 1. Fast Account Registration: Visit and register with your email in just one minute. and register with your email in just one minute. 2. Claim Your $100 Free Mining Bonus: All new users receive a free 1-day contract worth $100, with estimated earnings up to $1.35. All new users receive a free 1-day contract worth $100, with estimated earnings up to $1.35. 3. Choose a High-Yield Plan: Select from a wide variety of BTC and DOGE mining contracts with flexible durations and stable daily returns. Select from a wide variety of BTC and DOGE mining contracts with flexible durations and stable daily returns. 4. Multi-Currency Payment, Instant Start: Pay using BTC, USDT, ETH, or DOGE—mining begins automatically after payment, no manual setup needed. Pay using BTC, USDT, ETH, or DOGE—mining begins automatically after payment, no manual setup needed. 5. Track Your Earnings in Real-Time: The user dashboard provides transparent insights into daily profits, balances, contract progress, and withdrawal history. The user dashboard provides transparent insights into daily profits, balances, contract progress, and withdrawal history. 6. Withdraw or Reinvest: Once your account reaches $200, withdraw at any time or reinvest into a new plan to enjoy compound growth. If you're searching for 'how to mine Bitcoin without hardware' or 'best Bitcoin cloud mining app for beginners,' Miningcoop is the ideal starting point. It offers a simple, secure, and beginner-friendly gateway into the world of crypto passive income. Trusted by Millions Worldwide: Miningcoop Ranked Among the Safest Cloud Mining Platforms of 2025 As of 2025, Miningcoop boasts over 1 million active users across 150+ countries and regions, making it one of the most widely adopted and trusted Bitcoin and Dogecoin cloud mining platforms globally. With consistent 4.6+ star ratings on Trustpilot , Reddit, and Google Reviews, Miningcoop ranks at the top in categories such as 'legal, verifiable, and high-yield cloud mining sites.' On the security front, Miningcoop has implemented cold wallet-based multi-layered encryption systems, AI-driven fraud detection, tiered firewalls, and behavior analysis technologies to effectively prevent hacking and fraudulent activity. The platform is also deeply integrated with world-leading mining pools to ensure 99.9% uptime and globally balanced load distribution. Conclusion: The Most Trusted Bitcoin Cloud Mining Platform of 2025 Offering Leading Investment Solutions As cloud mining enters a new era of compliance and intelligent efficiency, choosing a platform that is legal, secure, and high-yield is more important than ever. Backed by AI-powered hash rate scheduling, fully transparent profit mechanisms, and a world-class user experience, Miningcoop has earned its place as one of the most recommended crypto investment platforms of 2025. Start mining smarter today — visit and explore the leading Bitcoin and Dogecoin cloud mining solution of 2025. Begin your automated passive crypto income journey with confidence. Disclaimer: The information provided in this press release is not a solicitation for investment, nor is it intended as investment advice, financial advice, or trading advice. Cryptocurrency mining and staking involves risk. There is potential for loss of funds. It is strongly recommended you practice due diligence, including consultation with a professional financial advisor, before investing in or trading cryptocurrency and securities. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
